Dr. Frank Alexander Parke MD

Recommended Articles

• Julian Lennon: A Global Advocate for Lupus Awareness

  Julian Lennon, the son of the hugely-popular Beatle star, the late John Lennon, is an outspoken advocate of the lupus cause. After his smash album Valotte, and his four other albums, Lennon has been out of the spotlight and he has been focusing on other types of art, such as photography, painting,...

• The Reality Behind Juvenile-Onset Fibromyalgia

  Over time, more and more health conditions have been discovered, which has ultimately led to a more informed healthcare system. These breakthroughs have been thanks to a neverending goal of creating more efficient treatment options, which is being done as technology improves and becomes more...

• PET Scans Reveal Neurochemical Changes in Fibromyalgia Patients

  Fibromyalgia is a condition where you feel almost constant pain caused by inflammation all over the body, including joints, organs, and skin. Now brain scans and an advanced imaging test called positron emission tomography, or PET, show that there is a neurochemical change in the brains of those who...

• Different Types of Physicians Explained

  Doctors or physicians are categorized according to different factors including medical specialties and subspecialties. Most doctors specialize in a specific area of medicine. This article provides a summary of the different types of doctors in the medical field. AllergistsAllergists are also...

• Letting Go of Lupus Guilt

  Once the person has been diagnosed with lupus, it is usual to have too many questions and go through various emotional phases. How someone reacts to the disease varies from person to person, from complete refusal to accept the condition, to aggression or even depression. These phases keep changes...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...